The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results published in ASCO’s Journal of Clinical Oncology.
…
continue reading
Parsha & Pizza
…
continue reading
Just Coolin is where Bee-Bop meets Hip-Hop and all flavors of Jazz. We show and tell the history of past and current music giants. Follow us on YouTube and our website www.justcoolin.com to catch up on past episodes! The jcoolin’s Podcast is Jazz , Real & Black ,Hip Hop music untold stories.
…
continue reading
JCO Oncology Practice (JCO OP) provides oncologists and other oncology professionals with information and tools to enhance practice efficiency and promote a high standard for quality of patient care. The goal of JCO OP is to be the authoritative resource on clinical and administrative management for practicing oncologists. The Journal includes original research, feature articles, and section columns on various issues pertinent to daily practice operations, all of which are subject to peer re ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: Assisted Reproduction in Breast Cancer Patients
22:48
22:48
Play later
Play later
Lists
Like
Liked
22:48
In this episode of JCO Article Insights, Dr. Giselle de Souza Carvalho interviews Dr. Hatem Azim and Dr. Ann partridge on their JCO article “Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy,” TRANSCRIPT Giselle Carvalho: Welcome to the JCO Article Insights e…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multi-Cancer Early Detection Testing for High-Risk Patients
30:29
30:29
Play later
Play later
Lists
Like
Liked
30:29
Host Dr. Davide Soldato interviews Dr. Sana Raoof to discuss the JCO article Turning the Knobs on Screening Liquid Biopsies for High-Risk Populations: Potential for Dialing Down Invasive Procedures. TRANSCRIPT Dr. Davide Soldato: Hello, and welcome to JCO After Hours, the podcast where we sit down with others from some of the latest articles publis…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
17:27
17:27
Play later
Play later
Lists
Like
Liked
17:27
In this episode of JCO Article Insights, Rohit Singh interviews Dr. Ticiana Leal on the editorial, "Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade." TRANSCRIPT The guests' disclosures can be found in the transcript. Dr. Rohit Singh: Hello and welcome to JCO’s Article Insights. I am your host Rohit Singh and today we will be discu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Functional Disability Among US Cancer Survivors
16:12
16:12
Play later
Play later
Lists
Like
Liked
16:12
Dr. Shannon Westin and her guest, Dr. Chao Cao, discuss the paper "Prevalence and Cancer-Specific Patterns of Functional Disability Among US Cancer Survivors, 2017-2022" recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Shannon Westin: Hello, everyone, and welcome to another episode of JC…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
CAR T-Cell Therapy for Richter’s Transformation
9:19
9:19
Play later
Play later
Lists
Like
Liked
9:19
In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Anti-CD19 Chimeric Antigen Receptor T-cell therapy for Richter’s Transformation: An International, Multicenter, Retrospective Study by Kittai, et al published in the Journal of Clinical Oncology March 29th, 2024. TRANSCRIPT The guest on this podcast episode has no disclosu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EAZ171: Predictors of TIPN in Black Women with Breast Cancer
14:38
14:38
Play later
Play later
Lists
Like
Liked
14:38
Dr. Shannon Westin and her guest, Dr. Bryan Schneider discuss the article “ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-induced Peripheral Neuropathy in Black Women with Early Stage Breast Cancer” recently published in the JCO and presented at the 2024 ASCO Annual Meeting. TRANSCRIPT The guest on this podcast epi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: Final Analysis of the Ro-CHOP Trial
8:49
8:49
Play later
Play later
Lists
Like
Liked
8:49
In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial" by Camus et al published Febr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Methylphenidate for Fatigue in Advanced Cancer
20:16
20:16
Play later
Play later
Lists
Like
Liked
20:16
Dr. Shannon Westin and her guest, Dr. Patrick Stone, discuss the article, Methylphenidate Versus Placebo for Treating Fatigue in People with Advanced Cancer, a Randomized, Double-Blind, Multicenter Placebo-Controlled Trial, recently published in JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Shannon Westin: Hello, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Introducing JCO Oncology Advances with Dr. Jonathan Friedberg and Dr. Pamela Kunz
16:36
16:36
Play later
Play later
Lists
Like
Liked
16:36
JCO Editor in Chief, Dr. Jonathan Friedberg interviews Dr. Pamela Kunz, Editor in Chief of the new premier open access journal, JCO Oncology Advances. Dr. Friedberg and Dr. Kunz discuss what is to come from the journal and the benefits of an open access journal. TRANSCRIPT Dr. Jonathan Friedberg: Hello and welcome to another episode of JCO After Ho…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Life of Billy Strayhorn Composer , Arranger ,Lyricist and Jazz Pianist for Duke Ellington
19:27
19:27
Play later
Play later
Lists
Like
Liked
19:27
Podcast is about Strayhorn music relationship with Ellington as the unknown author never being recognized for his contributions in JAZZ
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: Atezolizumab Plus Bevacizumab, Chemotherapy in EGFR, ALK NSCLC
11:29
11:29
Play later
Play later
Lists
Like
Liked
11:29
In this JCO Article Insights episode, Rohit Singh provides summary on two articles published in the April 10th issue of the Journal of Clinical Oncology. The first article, "Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)" describes…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Commonly Held Beliefs About Cancer Survivorship
17:37
17:37
Play later
Play later
Lists
Like
Liked
17:37
Dr. Shannon Westin and her guests, Dr. Emily S. Tonorezos and Dr. Michael Halpern, discuss their article, "Myths and Presumptions About Cancer Survivorship" recently published in the JCO. TRANSCRIPT The guests on this podcast episode have no disclosures to declare. Shannon Westin:Hello, everyone, and welcome to another episode of JCO After Hours, t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: Long Term Follow Up of the RESORT (E4402) and LYSA Study
10:05
10:05
Play later
Play later
Lists
Like
Liked
10:05
In this JCO Article Insights episode, Alexandra Rojek provides a summary on two long term follow studies: "Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study" by Sarkozy, et al published on December 18th, 2023 and "Long Term Follow Up of the RESORT Study (E4402): A Rando…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pembrolizumab in Patients With Advanced Cancers With HTMB
19:56
19:56
Play later
Play later
Lists
Like
Liked
19:56
Dr. Shannon Westin and her guests, Dr. Herbert Duvivier and Dr. Richard Schilsky, discuss the paper “Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study” published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Shan…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: Axillary Soft Tissue Involvement and Breast Cancer Prognosis
8:31
8:31
Play later
Play later
Lists
Like
Liked
8:31
In this JCO Article Insights episode, Giselle de Souza Carvalho provides a summary on "Pathologic Exploration of the Axillary Soft Tissue Microenvironment and Its Impact on Axillary Management and Breast Cancer Outcomes" by Naoum, et al and "Optimization of Breast Cancer Regional Nodal Management" by Braunstein et al published in the January 10, 20…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Omission of Radiotherapy after Breast-Conserving Surgery
20:42
20:42
Play later
Play later
Lists
Like
Liked
20:42
Dr. Shannon Westin and her guest, Dr. Reshma Jagsi, discuss the paper "Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA" recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Shannon Westin: Hello, ev…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Costs of Cancer Prevention in CDH1 Variant Carriers
23:33
23:33
Play later
Play later
Lists
Like
Liked
23:33
Dr. Shannon Westin and her guests, Dr. Jeremy Davis and patient advocate Kathryn Carr, discuss the paper "Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy" recently published and printed in the JCO. TRANSCRIPT Shannon Westin: Hello, everyone, and welcome to another episode of JCO After Hours, the pod…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: Low and Moderate Grade Adverse Events and the Patient Experience in Clinical Trials
9:50
9:50
Play later
Play later
Lists
Like
Liked
9:50
In this JCO Article Insights episode, Subodh Selukar summarized findings from the original article published in the January 2024 JCO issue: “The Importance of Low and Moderate Grade Adverse Events on Patients’ Treatment Experience and Treatment Discontinuation” and accompanying editorial “Patient Experience, Adverse Event Reporting, and Clinical Tr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Debunking Sex and Disentangling Gender From Oncology
23:09
23:09
Play later
Play later
Lists
Like
Liked
23:09
Dr. Shannon Westin and her guest, Dr. Ash Alpert and Spencer Adams, discuss the paper "Debunking Sex and Disentangling Gender From Oncology" recently published in the JCO. TRANSCRIPT The guests on this podcast episode have no disclosures to declare. Shannon Westin: Hello and welcome to JCO After Hours, the podcast where we get in depth on manuscrip…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Germline EGFR Mutations and Familial Lung Cancer
18:08
18:08
Play later
Play later
Lists
Like
Liked
18:08
Dr. Shannon Westin and her guests, Dr. Judy Garber and Dr. Geoffrey Oxnard, discuss the paper "Germline EGFR Mutations and Familial Lung Cancer" recently published in the JCO. TRANCRIPT The guest on this podcast episode has no disclosures to declare. Shannon Westin: Hello, and welcome to JCO After Hours, the podcast where we get in-depth on article…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: DYPD-Guided Dose Individualization and Survival Outcomes
20:40
20:40
Play later
Play later
Lists
Like
Liked
20:40
In this episode of JCO Article Insights, host Dr. Soldato discussed with Dr. Knikman and Dr. Cats the findings of a study that assesses the influence of fluoropyrimidine dosing based on DYPD genotype on both progression-free and overall survival. The article, featured in the December edition of JCO, presents groundbreaking and reassuring data. Furt…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Negative Impact of Prior Authorization on Patients with Cancer
18:19
18:19
Play later
Play later
Lists
Like
Liked
18:19
Dr. Shannon Westin and her guest, Dr. Michael Anne Kyle and Dr. Nancy L. Keating, discuss the paper "Prior Authorization and Association With Delayed or Discontinued Prescription Fills" recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Shannon Westin: Hello, everyone, and welcome to another e…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Role of Molecular Classification in Predicting Response to Radiation in Early Endometrial Cancer
23:06
23:06
Play later
Play later
Lists
Like
Liked
23:06
Dr. Shannon Westin and her guest, Dr. Nanda Horeweg and Dr. Carien Creutzberg, discuss the paper "Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer" recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: Impact of Physical Activity on Mortality and of BMI on Treatment-Related Adverse Events
11:39
11:39
Play later
Play later
Lists
Like
Liked
11:39
In this JCO Article Insights episode, Davide Soldato provides summary on two articles published in the November issues of the Journal of Clinical Oncology. The first article provides data on the prognostic effect of physical exercise on overall mortality and cancer-related mortality in a pan-cancer analysis of the PLCO study. The second article pro…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
23:23
23:23
Play later
Play later
Lists
Like
Liked
23:23
In this "Podcast Takeover," Dr. Lidia Schapira guest hosts to discuss with Dr. Shannon Westin her own JCO paper, which reports on the DUO-E Trial. Dr. Ramez Eskander also joins in this lively discussion. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Shannon Westin: Hello, everyone, and welcome to another episode of…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
JCO Article Insights: Safety and efficacy of a Novel ADC Targeting TROP-2 in Metastatic Non-Small Cell Lung Cancer (NSCLC)
27:37
27:37
Play later
Play later
Lists
Like
Liked
27:37
In this JCO Article Insights episode, Davide Soldato interviews Dr. Jacob Sands, medical oncologist at Dana Farber Cancer Institute (Boston, MA) and Assistant Professor at Harvard Medical School, on their paper “First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Da…
…
continue reading